Glin3: Assessment of the Glycemic Responses to Nutritional Products

Inclusion Criteria: * Age ≥ 18 and ≤ 65 years * Body mass index (BMI) between 18.5 and 27 kg/m² Exclusion Criteria: * Baseline fasting Glucose ≥6.1 at screening visit * Known history of gastrointestinal disease, bariatric surgery, AIDS, hepatitis, a history or presence of clinically important endocrine (including Type 1 or Type 2 diabetes mellitus), or any condition which might, in the opinion of the medical director either: 1) make participation dangerous to the subject or to others, or 2) affect the results. * Use of medications known to influence carbohydrate metabolism, gastrointestinal function or appetite, including, but not limited to adrenergic blockers, diuretics, thiazolidinediones, metformin and systemic corticosteroids within 4 weeks of the screening visit, or any medication which might, in the opinion of the medical director either: 1) make participation dangerous to the subject or to others, or 2) affect the results. * Major trauma or surgical event within 3 months of screening. * Known intolerance, sensitivity or allergy to test products. * Extreme dietary habits, as judged by the Investigator (i.e. Atkins diet, very high protein diets, etc.). * History of cancer in the prior two years, except for non-melanoma skin cancer.